Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
IBD
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - IBD
    Researchers Discover Mutations In Two Genes That Cause Early-Onset IBD - (DGNews)
    Isotretinoin Use Linked to Increased Risk of IBD: Presented at ACG - (DGDispatch)
    Patients With Ulcerative Colitis Who Have Worst Baseline Disease Are Most Likely to Relapse: Presented at ACG - (DGDispatch)
    TopAbstracts in IBD 10/27/2009 - (DGNews)
    Patients Previously on Steroids Maintain Remission From Ulcerative Colitis With Mesalamine Granules: Presented at ACG - (DGDispatch)

    News archive

     Recent webcasts/CME - IBD
    • Biologics in Crohn's Disease: Treating Early, Treating Long-Term
    • Advances in Medical Therapy for Crohn's Disease
      Advances in Surgical Treatments for Crohn's Disease
      Management Strategies for Complex Crohn's Disease Case Presentations
      Biologic Therapies III The New Agents

      Webcasts/CME archive

       Recent cases - IBD
        A 47-Year-Old Man with Neuro-Sweet Syndrome in Association with Crohn's Disease: A Case Report
        Tracheobronchitis in a Patient with Crohn's Disease
        Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review
        Crohn's Disease
        Pneumocystis Jiroveci Pneumonia and Pneumomediastinum in an Anti-Tnfalpha Naive Patient with Ulcerative Colitis

        Cases archive
          




        my personal edition > ibd > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Decades-Long Study Will Help Improve Surgery for Crohn's Disease

        NEW YORK, NY -- February 21, 2007 -- Decades of painstaking research has yielded the most in-depth look ever at the management of bowel stricture recurrence in patients who undergo surgery for Crohn's disease. The findings should provide much-needed guidance to surgeons and gastroenterologists battling this tough-to-manage intestinal disorder.

        Published in the journal Surgery, the study was led by Fabrizio Michelassi, MD, chairman of the Department of Surgery and the Lewis Atterbury Stimson Professor of Surgery at Weill Cornell Medical College, and surgeon-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

        "These findings offer surgeons working with Crohn's patients a degree of clarity that just wasn't there before, and should greatly enhance the surgical management of this disease," says Michelassi.

        Among other findings, the study supports the notion that strictureplasty -- a bowel-sparing surgical procedure commonly used to correct Crohn's-related strictures -- is less likely to lead to stricture recurrence later on, compared to surgical excision (resection) of the stricture.

        Crohn's disease involves a chronic inflammation of the digestive tract, often resulting in pain and diarrhea. Disease onset typically occurs in young adulthood, and the disorder is characterized by strictures -- narrowings of the bowel -- which often require surgical excision or correction.

        In decades past, Crohn's patients typically underwent surgical removal of the bowel at the point of stricture, although in recent years, corrective, bowel-sparing "strictureplasties" have become much more common. Michelassi has been a pioneer in developing new strictureplasty techniques. But he says that, up till now, surgeons lacked good information on the long-term consequences of these operations compared with resection.

        Seeking to change all that, Michelassi launched this prospective, longitudinal study more than 20 years ago.

        "Beginning with my work as a young surgeon at the University of Chicago, I kept records from the very first patient I operated on with Crohn's disease in 1988. By 2001, I had already operated on more than a thousand patients," he explains.

        During each procedure, Michelassi took pictures and made detailed sketches of those areas subject to surgery. "So, if these patients came to me again 5 or 10 years later with a stricture recurrence, I could compare the location of the recurrence to the site of the original surgery," he says.

        Surgeons know that about one-third of patients who undergo Crohn's-related surgery will have a recurrence. However, since most Crohn's patients are young and prone to moving from city to city, only a long-term study at a major center could track enough patients to get a good picture of post-op trends over time.

        Michelassi was able to keep records on 981 patients who underwent a total of 1,132 procedures, 668 of which involved recurrent disease.

        The study yielded some interesting findings.

        "First of all, it validated the notion that strictureplasty carries a lower risk of stricture recurrence compared to resection," Michelassi says. "And if a recurrence does occur after strictureplasty, it is likely to happen much later than after resection." Recurrences after strictureplasty were also less likely to require a surgical excision of the affected area compared to recurrences occurring after resection, he says.

        The study also found that up to a third of recurrences occur away from the site of the original operation. Furthermore, the type and site of prior surgery appears to influence the pattern of recurrence, the researchers found. The study also provides new guidance on what surgeons call "prophylactic strictureplasty" -- procedures aimed at preventing stricture-related trouble.

        "Sometimes we encounter a stricture that isn't giving the Crohn's patient any symptoms right now. We know, though, that these strictures can lead to trouble in about 25% of cases," Michelassi explains. "Based on our findings, we would now advise that if an asymptomatic stricture can be fixed using bowel-sparing strictureplasty, then the surgeon should go ahead and perform that type of prophylactic procedure," he says. "However, if fixing the problem requires bowel resection, then we would advise leaving the stricture alone, because there's still a 75% chance it will not cause the patient any harm."


        SOURCE: NewYork-Presbyterian Hospital/Weill Cornell Medical Center



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send